PREPARATION AND OPTIMIZATION OF ONCE DAILY QUETIPINE FUMARATE SUSTAIN RELEASE TABLETS
DOI:
https://doi.org/10.22159/ajpcr.2026v19i2.57498Keywords:
In vitro dissolution, HPMC K100M, Polyox WSR N80Abstract
Objective: Quetiapine fumarate (QF) belongs to the atypical antipsychotic class. The elimination half-life of QF is 6 h necessitates the development of sustain release (SR) formulation. In the current research, two polymers, HPMC K100M and Polyox WSR N80, were used in combination as per the central composite design (CCD) with an objective of sustained drug release for 24 h with low initial burst release.
Methods: The SR matrix tablets of QF were prepared by wet granulation method. Fourier transform infrared and differential scanning calorimetry study for the physical mixture of QF with HPMC K100M and Polyox WSR N80 in 1:1 ratio demonstrated compatibility between the drug and polymers. The selection of the optimum formulation highlights the precision of CCD in optimizing the formulation parameters to achieve the desired release profile.
Results: The integration of two polymers, HPMC K100M (58.2 mg/tablet) and Polyox WSR N80 (44.8 mg/tablet), proved effective in modulating the drug release dynamics. Specifically, the polymers synergistically contributed in attaining the desired responses vis-à-vis Q1 9.73%, t50 10.45 h, and Q18 82.46%, thereby ensuring minimized initial burst release and sustained release of QF over 24 h.
Conclusion: The development of a once-daily formulation aligns with modern patient-centric approaches in pharmaceutical design, catering to convenience and improving quality of life for patients requiring long-term therapy.
Downloads
References
1. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: An atypical antipsychotic. Clin Pharmacokinet. 2001;40(7):509-22. doi: 10.2165/00003088-200140070-00003, PMID 11510628
2. Goren JL, Levin GM. Quetiapine, an atypical antipsychotic. Pharmacotherapy. 1998;18(6):1183-94. doi: 10.1002/j.1875-9114.1998. tb03136.x, PMID 9855315
3. Oruch R, Pryme I, Fasmer O, Lund A. Quetiapine: An objective evaluation of pharmacology, clinical uses and intoxication. Pharmacol Toxicol. 2020;8(4):1-26.
4. Cutler AJ, Goldstein JM, Tumas JA. Dosing and switching strategies for quetiapine fumarate. Clin Ther. 2002;24(2):209-22. doi: 10.1016/ S0149-2918(02)85018-4, PMID 11911552
5. Agarwal S, HariKumar SL, Negi P, Upadhyay N, Garg R. Quetiapine fumarate loaded nanostructured lipid carrier for enhancing oral bioavailability: Design, development and pharmacokinetic assessment. Curr Drug Deliv. 2021;18(2):184-98. doi: 10.2174/1567201817999200 728135119, PMID 32723273
6. Kim DW, Weon KY, Hong EP, Chung EK, Lee KT. Comparative physicochemical and pharmacokinetic properties of quetiapine and its active metabolite norquetiapine. Chem Pharm Bull (Tokyo). 2016;64(11):1546-54. doi: 10.1248/cpb.c16-00223, PMID 27803466
7. Teixeira MT, Sa-Barreto LL, Taveira SF, Gratieri T, Gelfuso GM, Marreto RN, et al. The influence of matrix technology on the subdivision of sustained release matrix tablets. AAPS PharmSciTech. 2020;21:8.
8. Sarangi DK, Patro CS, Patra CN, Sahoo NK, Das NR, Kaur K, et al. In vivo assessment, formulation, characterization and enhancing pharmacotherapy of encapsulated mini tablets for immediate release sildenafil citrate and sustained release bosentan. Results Chem. 2024;9:101652. doi: 10.1016/j.rechem.2024.101652
9. Diwedi R, Alexandar A, Chandrasekar M. Preparation and in vitro evaluation of sustained release tablet formulations of metformin HCL. Asian J Pharm Clin Res. 2012;5(1):45-8.
10. Ram D, Pankhaniya H. Formulation, evaluation and optimization of sustained-release drug delivery system of cisapride tablet. Int J Pharm Pharm Sci. 2021;13(9):56-62. doi: 10.22159/ijpps.2021v13i9.41799
11. Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007;57(4):479-89. doi: 10.2478/v10007- 007-0038-0, PMID 18165191
12. Patra CN, Padhy S, Sen T, Bhattacharya S, Swain S, Sruti J, et al. Formulation development and evaluation of SR matrix tablets of stavudine. Ind J Pharm Educ Res. 2013;47:214-20.
13. Vanza JD, Patel RB, Dave RR, Patel MR. Polyethylene oxide and its controlled release properties in hydrophilic matrix tablets for oral administration. Pharm Dev Technol. 2020;25(10):1169-87. doi: 10.1080/10837450.2020.1808015, PMID 32772604
14. Martin LM, Rajabi-Siahboomi AR. Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices. Hydrophilic Matrix Tablets for Oral Controlled Release. Berlin: Springer; 2014. p. 123-41.
15. Malladi M, Jukanti R. Floating pulsatile drug delivery system of famotidine: Design, statistical optimization, and in vitro evaluation. Int J Pharm Pharm Sci. 2016;8(5):169-81.
16. Aleti R, Baratam SR, Jagirapu B, Kudamala S. Formulation and evaluation of metformin hydrochloride and gliclazide sustained release bilayer tablets: A combination therapy in management of diabetes. Int J App Pharm. 2021;13(5):343-50. doi: 10.22159/ijap.2021v13i5.41339
17. Garg N, Pandey P, Kaushik D, Dureja H. Development of novel multifunction directly compressible co-processed excipient by melt granulation technique. Int J Pharm Investig. 2015;5(4):266-74. doi: 10.4103/2230-973X.167692, PMID 2668219718. Rantanen J, Antikainen O, Mannermaa JP, Yliruusi J. Use of the near-infrared reflectance method for measurement of moisture content during granulation. Pharm Dev Technol. 2000;5(2):209-17. doi: 10.1081/ PDT-100100536, PMID 10810751
19. Sinko PJ. Martin’s Physical Pharmacy and Pharmaceutical Sciences. Philadelphia, PA: Lippincott Williams & Wilkins; 2023.
20. Kumari PV, Rao YS. Formulation and evaluation of orodispersible tablets of donepezil hydrochloride. Int J Curr Pharm Res. 2020;12:45-51. doi: 10.22159/ijcpr.2020v12i4.39049
21. Aulton ME, Taylor K. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. Amsterdam: Elsevier Health Sciences; 2013.
22. Chhajed S, Agrawal S, Bastikar V, Gosavi R, Kunte S, Wagh R. Estimation of quetiapine in bulk drug and tablet dosage form. Int J Chem Sci. 2009;7(2):951-60.
23. Khagga B, Kaitha MV, Dammu R, Mogili S. ICH guidelines-“Q” series (quality guidelines)-A review. GSC Biol Pharm Sci. 2019;6(3):89-106. doi: 10.30574/gscbps.2019.6.3.0034
24. Bhaskararao P, Sarika M, Madhavi CL, Kollipara MG, Prashanthi G. The industrial importance of technology transfer for analytical method development and validation-application to vilazodone hydrochloride dosage form. Int J Chem Res. 2024;8:12-7. doi: 10.22159/ijcr.2024v8i4.235
25. Ghanbari E, Picken SJ, van Esch JH. Analysis of differential scanning calorimetry (DSC): Determining the transition temperatures, and enthalpy and heat capacity changes in multicomponent systems by analytical model fitting. J Therm Anal Calorim. 2023;148(22):12393-409. doi: 10.1007/s10973-023-12356-1
26. Tahara K, Yamamoto K, Nishihata T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J Control Release. 1995;35(1):59-66. doi: 10.1016/0168-3659(95)00021-Y
27. Sujja-Areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur J Pharm Sci. 1998;6(3):207-17. doi: 10.1016/ S0928-0987(97)00072-9, PMID 9795062
28. Sung KC, Nixon PR, Skoug JW, Ju TR, Gao P, Topp EM, et al. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int J Pharm. 1996;142(1):53-60. doi: 10.1016/0378- 5173(96)04644-3
29. Patra CN, Swain S, Mahanty S, Panigrahi KC. Design and characterization of aceclofenac and paracetamol spherical crystals and their tableting properties. Powder Technol. 2015;274:446-54. doi: 10.1016/j.powtec.2015.01.053
30. Jammula S, Patra CHN, Swain S, Panigrahi KC, Nayak S, Dinda SC, et al. Design and characterization of cefuroxime axetil biphasic floating minitablets. Drug Deliv. 2015;22(1):125-35. doi: 10.3109/10717544.2013.871603, PMID 24417642
31. Prakash SS, Patra CN, Santanu C, Kumar PH, Patro VJ, Devi MV. Studies on flowability, compressibility and in-vitro release of Terminalia chebula fruit powder tablets. Iran J Pharm Res. 2011;10(3):393.
32. Talevi A, Ruiz ME. Korsmeyer-Peppas, Peppas-Sahlin, Brazel-Peppas: Models of Drug Release. The ADME Encyclopedia: A Comprehensive Guide on Biopharmacy and Pharmacokinetics. Berlin: Springer; 2022. p. 613-21.
33. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25-35. doi: 10.1016/0378-5173(83)90064-9
34. Lee PI. Kinetics of drug release from hydrogel matrices. J Control Release. 1985;2:277-88. doi: 10.1016/0168-3659(85)90051-3
Published
How to Cite
Issue
Section
Copyright (c) 2025 Dinesh Kumar Das, ANJAN KUMAR, Ch Niranjan Patra
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.